Credibility Index › Doximity (DOCS) › Q2'26

Doximity (DOCS) Q2'26 Earnings Call

Management-credibility review · call November 6, 2025
B+
Overall grade
B+
Financial quality
The sleeper story is integrated programs hitting 40% of bookings - this isn't just a sales tactic, it's a business model moat that locks in longer contracts and smoother revenue while forcing competitors into point solutions. The obvious AI narrative is real (650K workflow users, enterprise traction) but management deliberately slowed monetization for adoption. The binding constraint is their own restraint - they're prioritizing user experience over revenue conversion despite clear enterprise demand. As Jeff said, 'we're not trying to actively sell or monetize yet' despite 'dozens of health systems already signed on.' My view changes if Q3 shows integrated program penetration stalling or if they're forced to accelerate AI monetization due to competitive pressure.

The 30-second version

What changed this quarter

MetricPriorThis quarter
Revenue$146M (15% YoY)$169M (23% YoY)
Adj EBITDA Margin55%60%
Free Cash Flow$60M (+52% YoY)$92M (+37% YoY)
Net Revenue Retention118%118%
$500K+ Customers120 (+17% YoY)121 (+16% YoY)
AI QAUs5x YoY growth50% QoQ growth
Workflow Tool Users630K650K
Telehealth Daily Volume200K calls/day300K calls/day

Accountability tracked

7 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →
Other DOCS quarters: Q4'25 · Q1'26 · Q3'26 · Q4'26
Full DOCS credibility scorecard →
About Research ↗ · Credibility Index · Missed Promises · Screens · 13F Holdings · Subscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Grades, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.